keyword
https://read.qxmd.com/read/38529632/incorporation-of-drone-technology-into-the-chain-of-survival-for-ohca-estimation-of-time-needed-for-bystander-treatment-of-ohca-and-cpr-performance
#21
JOURNAL ARTICLE
Monique A Starks, Audrey L Blewer, Christine Chow, Edward Sharpe, Lee Van Vleet, Evan Arnold, Daniel M Buckland, Anjni Joiner, Denise Simmons, Cynthia L Green, Daniel B Mark
BACKGROUND: Drone-delivered automated external defibrillators (AEDs) hold promises in the treatment of out-of-hospital cardiac arrest. Our objective was to estimate the time needed to perform resuscitation with a drone-delivered AED and to measure cardiopulmonary resuscitation (CPR) quality. METHODS: Mock out-of-hospital cardiac arrest simulations that included a 9-1-1 call, CPR, and drone-delivered AED were conducted. Each simulation was timed and video-recorded...
March 26, 2024: Circulation. Cardiovascular Quality and Outcomes
https://read.qxmd.com/read/38529422/advancements-in-mitraclip-intervention-for-mitral-regurgitation-a-comprehensive-review-and-comparative-analysis-of-clinical-trials
#22
REVIEW
Shitij Shrivastava, Shashwat Shrivastava, Sai Vishnu Vardhan Allu, Patrik Schmidt, Moiud Mohyeldin, Abeer Qasim
This comprehensive review explores the evolution and clinical impact of MitraClip intervention in the management of mitral regurgitation. Mitral regurgitation results from dysfunction in the mitral valve (MV) apparatus. The MitraClip Clip Delivery System was approved by the Food and Drug Administration (FDA) in 2013. The discussion delves into the procedural foundation of MitraClip intervention, primarily based on Alfieri's technique of edge-to-edge leaflet approximation. As highlighted by key clinical trials, including Endovascular Valve Edge-to-Edge Repair (EVEREST) II Trial, Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) Trial, and Percutaneous Repair with the MitraClip Device for Severe Functional/Secondary Mitral Regurgitation (MITRA-FR) trial, the efficacy and safety of MitraClip were evaluated in comparison to surgical interventions and guideline-directed medical therapy...
February 2024: Curēus
https://read.qxmd.com/read/38529099/clinical-presentation-and-6-month-outcomes-of-patients-with-peripartum-cardiomyopathy-in-indonesia
#23
JOURNAL ARTICLE
Hawani Sasmaya Prameswari, Triwedya Indra Dewi, Melawati Hasan, Erwan Martanto, Astri Astuti, Aninka Saboe, Charlotte Johanna Cool
BACKGROUND: Due to the rarity of peripartum cardiomyopathy (PPCM) globally, baseline characteristic data for PPCM patients are still scarce. Therefore, this study aims to determine the baseline characteristics and 6-month outcomes of PPCM patients in Indonesia. METHODS: From January 2014 to December 2021, all PPCM patients aged ≥18 years who were admitted to Dr. Hasan Sadikin General Hospital in Bandung, Indonesia, participated in this single-center, prospective cohort study...
2024: International Journal of General Medicine
https://read.qxmd.com/read/38526748/planting-the-seed-for-blood-pressure-control-the-role-of-plant-based-nutrition-in-the-management-of-hypertension
#24
REVIEW
Justin A Charles, Nilofer Khan Habibullah, Saul Bautista, Brenda Davis, Shivam Joshi, Sarah C Hull
PURPOSE OF REVIEW: Hypertension results in significant morbidity, mortality, and healthcare expenditures. Fortunately, it is largely preventable and treatable by implementing dietary interventions, though these remain underutilized. Here, we aim to explore the role of healthy dietary patterns in hypertension management and describe approaches for busy clinicians to address nutrition effectively and efficiently with patients. RECENT FINDINGS: DASH, Mediterranean, vegetarian, and vegan diets that include minimally processed, plant-based foods as core elements have consistently shown positive effects on hypertension...
March 25, 2024: Current Cardiology Reports
https://read.qxmd.com/read/38526578/british-societies-guideline-on-the-management-of-emergencies-in-implantable-left-ventricular-assist-device-recipients-in-transplant-centres
#25
JOURNAL ARTICLE
Waqas Akhtar, Veronica Rial Baston, Marius Berman, Sai Bhagra, Colin Chue, Charles D Deakin, Jonathan R Dalzell, Joel Dunning, John Dunning, Roy S Gardner, Kristine Kiff, Shishir Kore, Sern Lim, Guy MacGowan, Ian Naldrett, Marlies Ostermann, Sofia Pinto, Stephen Pettit, Fernando Riesgo Gil, Alex Rosenberg, Antonio Rubino, Rana Sayeed, Joao Sequeira, Neil Swanson, Steven Tsui, Christopher Walker, Stephen Webb, Andrew Woods, Rajamiyer Ventkateswaran, Christopher T Bowles
An implantable left ventricular assist device (LVAD) is indicated as a bridge to transplantation or recovery in the United Kingdom (UK). The mechanism of action of the LVAD results in a unique state of haemodynamic stability with diminished arterial pulsatility. The clinical assessment of an LVAD recipient can be challenging because non-invasive blood pressure, pulse and oxygen saturation measurements may be hard to obtain. As a result of this unusual situation and complex interplay between the device and the native circulation, resuscitation of LVAD recipients requires bespoke guidelines...
March 25, 2024: Intensive Care Medicine
https://read.qxmd.com/read/38526192/echocardiography-in-the-neonatal-unit-current-status-and-future-prospects
#26
REVIEW
Yogen Singh
INTRODUCTION: Traditionally echocardiography was used by pediatric cardiologists to diagnose congenital heart defects in neonates. Formalized neonatal hemodynamic fellowships have been established where neonatologists acquire advanced echocardiographic skills to gain anatomical, physiological, and hemodynamic information in real time and utilize this information in making a timely and accurate physiology-based clinical decision. AREA COVERED: Differences between a comprehensive formal structural echocardiography, neonatologist performed targeted echocardiography and limited assessment on point-of-care-ultrasonography for specific indications have been covered...
March 25, 2024: Expert Review of Medical Devices
https://read.qxmd.com/read/38525767/an-aminoglycoside-sparing-regimen-with-double-beta-lactam-to-successfully-treat-granulicatella-adiacens-prosthetic-aortic-valve-endocarditis-time-to-change-paradigm
#27
Alberto Pagotto, Floriana Campanile, Paola Conti, Francesca Prataviera, Paola Della Siega, Sarah Flammini, Simone Giuliano, Luca Martini, Davide Pecori, Assunta Sartor, Maria Screm, Tosca Semenzin, Carlo Tascini
(1) Background: Granulicatella adiacens is a former nutritionally variant streptococci (NVS). NVS infective endocarditis (IE) is generally characterized by a higher rate of morbidity and mortality, partially due to difficulties in choosing the most adequate microbiological culture method and the most effective treatment strategy, and partially due to higher rates of complications, such as heart failure, peripheral septic embolism, and peri-valvular abscess, as well as a higher rate of valve replacement. Depending on the affected valve (native valve endocarditisNVE, or prosthetic valve endocarditisPVE), the American Heart Association (AHA) 2015 treatment guidelines (GLs) suggest penicillin G, ampicillin, or ceftriaxone plus gentamicin (2 weeks for NVE and up to 6 weeks for PVE), while vancomycin alone may be a reasonable alternative in patients who are intolerant of β-lactam therapy...
March 14, 2024: Infectious Disease Reports
https://read.qxmd.com/read/38522429/the-efficacy-of-nursing-interventions-in-preventing-surgical-site-infections-in-patients-undergoing-surgery-for-congenital-heart-disease
#28
JOURNAL ARTICLE
Ping He, Yue Hai
Surgical site infections (SSIs) pose significant risks to patients undergoing surgery for congenital heart disease (CHD), impacting recovery and increasing healthcare burdens. This study assesses the efficacy of targeted nursing interventions in reducing SSIs and enhancing wound healing in this vulnerable patient group. A prospective cohort study was conducted from January 2022 to August 2023 at a single institution, involving 120 paediatric patients divided into control (standard postoperative care) and observation (specialized nursing interventions) groups...
April 2024: International Wound Journal
https://read.qxmd.com/read/38521118/subclinical-myocardial-damage-after-anthracycline-chemotherapy-in-japanese-patients-with-breast-cancer
#29
JOURNAL ARTICLE
Kenji Nakatsuma, Neiko Ozasa, Mikiko Ohno, Hiroshi Ishiguro, Manabu Minami, Eiichiro Nishi, Masakazu Toi, Koh Ono, Takeshi Kimura
BACKGROUND: Data on the incidence, timing, and severity of myocardial damage after anthracycline-based chemotherapy (AC) in Japanese patients with breast cancer are limited. METHOD: We evaluated cancer therapy-related cardiac dysfunction (CTRCD) in Japanese women with breast cancer (n = 51) after the first AC according to the definitions of the 2022 European Society of Cardiology onco-cardiology guideline, including assessment of high-sensitivity troponin I (TnI) and B-type natriuretic peptide (BNP) levels...
March 21, 2024: Journal of Cardiology
https://read.qxmd.com/read/38520987/adherence-to-the-atrial-fibrillation-better-care-pathway-and-its-associated-factors-among-rural-patients-with-atrial-fibrillation-in-china-a-cross-sectional-study
#30
JOURNAL ARTICLE
Xiaomin Zhang, Wenxuan Wang, Jianqing Zeng, Qirao Ye, Xinwei Lai, Xiaomei Cai, Xiulin Diao, Jun Huang, Kun Li
BACKGROUND: The atrial fibrillation better care (ABC) pathway is an effective strategy for the integrated management of atrial fibrillation (AF). Current data on adherence to the ABC pathway among rural patients with AF in China are limited. OBJECTIVES: To investigated adherence to the ABC pathway and its associated factors among rural patients with AF in China. METHODS: In the cross-sectional study, we recruited 870 rural patients with AF from July 2022 to July 2023 in China...
March 22, 2024: Heart & Lung: the Journal of Critical Care
https://read.qxmd.com/read/38520314/echocardiographic-haemodynamic-monitoring-in-the-context-of-heartmate-3%C3%A2-therapy-a-systematic-review
#31
JOURNAL ARTICLE
Linus Ohlsson, Joanna-Maria Papageorgiou, Tino Ebbers, Meriam Åström Aneq, Éva Tamás, Hans Granfeldt
AIMS: While echocardiography remains essential within haemodynamic monitoring of durable mechanical circulatory support, previous echocardiographic guidelines are missing scientific evidence for the novel HeartMate 3™ (HM3) system. Accordingly, this review aims to summarize available echocardiographic evidence including HM3. METHODS AND RESULTS: This systematic review adhered to the PRISMA 2020 guidelines. Searches were conducted during August 2023 across PubMed, Embase, and Google Scholar using specific echocardiographic terms combined with system identifiers...
March 23, 2024: ESC Heart Failure
https://read.qxmd.com/read/38519808/efficacy-of-intravenous-iron-in-patients-with-heart-failure-with-reduced-ejection-fraction-and-iron-deficiency-a-systematic-review-and-meta-analysis-of-randomized-control-trials
#32
Andrew Sephien, Denisse Camille Dayto, Tea Reljic, Xavier Prida, Joanna M Joly, Matthew Tavares, Jason N Katz, Ambuj Kumar
BACKGROUND: The European Society of Cardiology (ESC) provided a focused update to the 2021 Guideline for the Management of Heart Failure, now providing a 1A recommendation for intravenous iron in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency (ID). However, the findings from randomized controlled trials (RCT) are mixed. This systematic review of RCTs aims to provide an update and synthesize the evidence addressing the association of intravenous iron with patient-based outcomes in patients with HFrEF and ID...
March 22, 2024: American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions
https://read.qxmd.com/read/38517604/assessing-regurgitation-severity-adverse-remodeling-and-fibrosis-with-cmr-in-aortic-regurgitation
#33
REVIEW
Mujtaba Saeed, Akila Bersali, Amr Darwish, Fatima Qamar, Dimitrios Maragiannis, Kinan Carlos El-Tallawi, Maan Malahfji, Dipan J Shah
PURPOSE OF REVIEW: Cardiac magnetic resonance (CMR) is emerging as a valuable imaging modality for the assessment of aortic regurgitation (AR). In this review, we discuss the assessment of AR severity, left ventricular (LV) remodeling, and tissue characterization by CMR while highlighting the latest studies and addressing future research needs. RECENT FINDINGS: Recent studies have further established CMR-based thresholds of AR severity and LV remodeling that are associated with adverse clinical outcomes, and lower than current guideline criteria...
March 22, 2024: Current Cardiology Reports
https://read.qxmd.com/read/38517253/ultra-early-hemostatic-therapy-for-acute-intracerebral-hemorrhage-an-updated-review
#34
JOURNAL ARTICLE
Michael Fortunato, Galadu Subah, Anish D Thomas, Bridget Nolan, Monica Mureb, Anaz Uddin, Kiran Upadhyay, Jonathan V Ogulnick, Nitesh Damodara, Colleen Bond, Chirag D Gandhi, Stephan A Mayer, Fawaz Al-Mufti
Intracerebral hemorrhage (ICH) is the second most common type of stroke, accounting for approximately 10-20% of all strokes, and is linked to severe neurological disability and death. Since the most accurate predictor of outcome in patients with ICH is hematoma volume, there is a great need for pharmacologic therapy that can reduce hematoma expansion and resultant mass effect and edema. This is especially critical within the ultra-early window of 3-4 hours after the presentation. Hemostatic therapies are exceptionally important for those patients taking antiplatelet or anticoagulant medications to reverse the effects of these medications and therefore prevent hematoma expansion...
March 21, 2024: Cardiology in Review
https://read.qxmd.com/read/38516780/clinical-guideline-for-preimplantation-genetic-testing-in-inherited-cardiac-diseases
#35
JOURNAL ARTICLE
Job A J Verdonschot, Debby M E I Hellebrekers, Vanessa P M van Empel, Malou Heijligers, Sonja de Munnik, Edith Coonen, Jos C M F Dreesen, Arthur van den Wijngaard, Han G Brunner, Masoud Zamani Esteki, Stephane R B Heymans, Christine E M de Die-Smulders, Aimée D C Paulussen
BACKGROUND: Preimplantation genetic testing (PGT) is a reproductive technology that selects embryos without (familial) genetic variants. PGT has been applied in inherited cardiac disease and is included in the latest American Heart Association/American College of Cardiology guidelines. However, guidelines selecting eligible couples who will have the strongest risk reduction most from PGT are lacking. We developed an objective decision model to select eligibility for PGT and compared its results with those from a multidisciplinary team...
March 22, 2024: Circulation. Genomic and Precision Medicine
https://read.qxmd.com/read/38515385/physician-perceptions-attitudes-and-strategies-towards-implementing-guideline-directed-medical-therapy-in-heart-failure-with-reduced-ejection-fraction-a-survey-of-the-heart-failure-association-of-the-esc-and-the-esc-council-for-cardiology-practice
#36
JOURNAL ARTICLE
Gianluigi Savarese, Felix Lindberg, Ruxandra M Christodorescu, Marc Ferrini, Thomas Kumler, Konstantinos Toutoutzas, Giuseppe Dattilo, Antoni Bayes-Genis, Brenda Moura, Offer Amir, Mark C Petrie, Petar Seferovic, Ovidiu Chioncel, Marco Metra, Andrew J S Coats, Giuseppe M C Rosano
AIMS: Recent guidelines recommend four core drug classes (renin-angiotensin system/angiotensin receptor-neprilysin inhibitor [RASi/ARNi], beta-blocker, mineralocorticoid receptor antagonist [MRA], and sodium-glucose cotransporter 2 inhibitor [SGLT2i]) for the pharmacological management of heart failure (HF) with reduced ejection fraction (HFrEF). We assessed physicians' perceived (i) comfort with implementing the recent HFrEF guideline recommendations; (ii) status of guideline-directed medical therapy (GDMT) implementation; (iii) use of different GDMT sequencing strategies; and (iv) barriers and strategies for achieving implementation...
March 22, 2024: European Journal of Heart Failure
https://read.qxmd.com/read/38515335/long-term-cost-effectiveness-of-transcatheter-mitral-valve-repair-in-%C3%A2-hf-patients-with-secondary-mitral-regurgitation
#37
JOURNAL ARTICLE
Younan Yao, Ziyou Zhou, Tian Geng, Anping Cai, Tian Li, Junqing Yang, Jiyan Chen, Liwen Li
AIMS: The long-term cost-effectiveness of MitraClip in heart failure patients with secondary mitral regurgitation is still unclear. This study aimed to evaluate the long-term cost-effectiveness of MitraClip added to guideline-directed medical therapy vs. guideline-directed medical therapy alone in heart failure patients with secondary mitral regurgitation from the perspective of the healthcare systems of mainland China, the United Kingdom, Germany, and the United States. METHODS AND RESULTS: A two-stage (decision + Markov) model was built...
March 22, 2024: ESC Heart Failure
https://read.qxmd.com/read/38514865/quality-reporting-of-randomized-controlled-trials-on-sglt2-inhibitors-for-heart-failure-a-comprehensive-assessment
#38
JOURNAL ARTICLE
YueGuang Yang, ShunWen Yang, YuBo Han, GuoLiang Zou, RuiNan Wang, Li Liu
Randomised controlled trials (RCTs) provide clinicians with the best evidence of the effectiveness of an intervention, and complete and transparent trial reports help to critically assess and use trial results. The objective of our study was to assess the quality of reporting in RCTs of sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for heart failure (HF) and identify factors associated with improved reporting quality. Two researchers conducted a comprehensive search in four databases (PubMed, Web of Science, EMBASE, and Cochrane)...
March 21, 2024: Scientific Reports
https://read.qxmd.com/read/38514328/-chinese-guidelines-for-the-diagnosis-and-treatment-of-heart-failure-2024
#39
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
March 24, 2024: Zhonghua Xin Xue Guan Bing za Zhi
https://read.qxmd.com/read/38513737/clinical-characteristics-treatment-trajectories-and-outcome-of-patients-with-dilated-cardiomyopathy-in-a-national-heart-failure-registry
#40
JOURNAL ARTICLE
Samuela Carigi, Piero Gentile, Mauro Gori, Denitza Tinti, Luisa De Gennaro, Giuseppe Leonardi, Francesco Orso, Anna Rita Felici, Maria Rosaria Catalano, Marina Floresta, Vittoria Rizzello, Donata Lucci, Lucio Gonzini, Renata De Maria, Marco Marini
BACKGROUND: Available data on the clinical characteristics and prognosis of patients with heart failure (HF) due to dilated cardiomyopathy (DCM) derive mainly from tertiary care centres for cardiomyopathies or from drug trial sub-studies, which may entail a referral bias. METHODS: From 2008 to 2021, we enrolled in a nationwide HF Registry 1886 DCM patients and 3899 with ischemic heart disease (IHD). RESULTS: Patients with DCM were younger, more often female, had more commonly recent onset HF, left bundle branch block, and showed higher LV end-diastolic volume and lower LVEF than IHD...
March 19, 2024: International Journal of Cardiology
keyword
keyword
116769
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.